Survival effects of erythropoiesis-stimulating agents (ESAs) in patients with breast cancer: A meta-analysis.
Brian Leyland-Jones
No relevant relationships to disclose
Matti S. Aapro
Consultant or Advisory Role - Amgen; Sandoz
Honoraria - Amgen; Hospira; Johnson & Johnson; Roche; Sandoz
Research Funding - Sandoz
Other Remuneration - Amgen; Hospira; Johnson & Johnson; Roche; Sandoz
Volker Moebus
Honoraria - Amgen; GlaxoSmithKline; Pfizer; Roche
Research Funding - Amgen; Johnson & Johnson; Novartis; Roche
Ulrike Nitz
Honoraria - Amgen; Sanofi
Joyce O'Shaughnessy
Honoraria - Amgen
Paolo Pronzato
Honoraria - Amgen; Janssen-Cilag
Michael Untch
No relevant relationships to disclose
Dianne Tomita
Employment or Leadership Position - Amgen
Stock Ownership - Amgen
Gerry C. Bohac
Employment or Leadership Position - Amgen
Stock Ownership - Amgen